![Cybin Inc. logo](/logos/CYBN.webp)
Cybin Inc.
AMEX:CYBN
Overview | Financials
Company Name | Cybin Inc. |
Symbol | CYBN |
Currency | USD |
Price | 0.45 |
Market Cap | 142,032,600 |
Dividend Yield | 0% |
52-week-range | 0.21 - 0.738 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Eric So L.L.B., LLB |
Website | https://www.cybin.com |
An error occurred while fetching data.
About Cybin Inc.
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD